Metraipolis › archive › dc_bc2fb24cc6fd

Efficacy and Cost-Effectiveness of Vonoprazan-Amoxicillin Dual Therapy Versus Esomeprazole-Bismuth Quadruple Therapy for Helicobacter pylori: A Propensity… — Europe PMC PMID:42197391

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42197391
DOI: 10.3390/microorganisms14051006
License (as archived): solo-consultazione
Archived: 2026-11-03T02:16:16.515Z
SHA-256 of the archived text: 8996a6a2c0693d1cdac977d246bf71cef23f7cf24320b2f9e9bb2d1b92b87222
Stable URL of this page: https://metraipolis.com/documento/dc_bc2fb24cc6fd

How to cite

Efficacy and Cost-Effectiveness of Vonoprazan-Amoxicillin Dual Therapy Versus Esomeprazole-Bismuth Quadruple Therapy for Helicobacter pylori: A Propensity… — Europe PMC PMID:42197391 — Europe PMC (en), https://europepmc.org/article/MED/42197391 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bc2fb24cc6fd (Metraipolis archive dc_bc2fb24cc6fd, sha256 8996a6a2c0693d1cdac977d246bf71cef23f7cf24320b2f9e9bb2d1b92b87222)

BibTeX

@misc{dcbc2fb24cc6fd,
  title = {Efficacy and Cost-Effectiveness of Vonoprazan-Amoxicillin Dual Therapy Versus Esomeprazole-Bismuth Quadruple Therapy for Helicobacter pylori: A Propensity… — Europe PMC PMID:42197391},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42197391},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bc2fb24cc6fd; sha256 8996a6a2c0693d1cdac977d246bf71cef23f7cf24320b2f9e9bb2d1b92b87222},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42197391. Agents can read the archived copy with the MCP tool read_document.